| Continuous Glucose Monitoring |
1 |
1 |
| Type 2 Diabetes Mellitus |
0 |
0.79 |
| Blood |
0 |
0.72 |
| Exercise |
0 |
0.36 |
| France |
0 |
0.36 |
| Hemoglobin |
0 |
0.36 |
| Hemoglobin A1c |
0 |
0.34 |
| Prediabetes |
0 |
0.29 |
| A-Scan Biometry |
0 |
0.12 |
| Adverse Effects |
0 |
0.12 |
| Artificial Intelligence |
0 |
0.12 |
| Endocrinology |
0 |
0.12 |
| Finger |
0 |
0.12 |
| Hospital |
0 |
0.12 |
| Hypoglycemia |
0 |
0.12 |
| Infectious Mononucleosis |
0 |
0.12 |
| Nutrition |
0 |
0.12 |
| Pharmacogenomics |
0 |
0.12 |
| Scan |
0 |
0.12 |
| Patient Safety |
0 |
0.11 |
| Care and Maintenance of Vision |
0 |
0.07 |
| Cataract |
0 |
0.07 |
| Genomic Medicine |
0 |
0.07 |
| Healthcare and Medical Technology |
0 |
0.07 |
| Herpes Simplex |
0 |
0.07 |
| Obesity |
0 |
0.07 |